2010
DOI: 10.1016/j.jse.2010.01.012
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of glenohumeral sepsis with a commercially produced antibiotic-impregnated cement spacer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
40
1

Year Published

2011
2011
2023
2023

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 67 publications
(42 citation statements)
references
References 24 publications
1
40
1
Order By: Relevance
“…Themislocleous et al recently published their series of 11 patients with a permanent cement spacer. They concluded that in the low-demand patient, one can expect infection and pain control, with limited shoulder function [11], and similar results were found in a more recent publication by Coffey and Crosby [12]. On the other hand, Verhelst et al found no difference in clinical outcome in a mixed retrospective series of patients undergoing either resection arthroplasty or a spacer implant for chronic shoulder infection of different pathogenesis [13].…”
Section: Introductionmentioning
confidence: 58%
“…Themislocleous et al recently published their series of 11 patients with a permanent cement spacer. They concluded that in the low-demand patient, one can expect infection and pain control, with limited shoulder function [11], and similar results were found in a more recent publication by Coffey and Crosby [12]. On the other hand, Verhelst et al found no difference in clinical outcome in a mixed retrospective series of patients undergoing either resection arthroplasty or a spacer implant for chronic shoulder infection of different pathogenesis [13].…”
Section: Introductionmentioning
confidence: 58%
“…They concluded that shoulder sepsis could be treated by spacer implantation, although they did not point out what benefit they achieved. 5 A recent report by Stine et al 20 again examined the use of a spacer in shoulder sepsis. These authors found no significant difference between patients treated with a permanent spacer and patients that were reimplanted.…”
Section: Discussionmentioning
confidence: 99%
“…This is in contrast to the results of other publications that showed no bone destruction even with longer follow-up. 5,30,33 These authors used moulded, well-fitting spacers or a commercially available implant. This might explain why our cohort had severe erosions.…”
Section: Discussionmentioning
confidence: 99%
“…Infection recurrence rates have been reported to range from 0% to 30% 65,68,72,73,75,76 . Crosby et al demonstrated that surgeon-constructed and commercially available articulating cement spacers impregnated with vancomycin alone or in combination with an aminoglycoside are both effective treatment techniques [77][78][79] . Articulating antibiotic cement spacers allow for the preservation of a soft-tissue envelope and can often act as the definitive implant in a patient with minimal functional demands 80 .…”
Section: Managementmentioning
confidence: 99%